Part 1: a matter of size: evaluating the growth-restricted neonate

Elizabeth J Lawrence1

  • 1NNP Group, Womack Army Medical Center-NICU, Ft. Bragg, NC, USA. elizabeth.lawrence@na.amedd.army.mil

Insights

Neonatal size classifications like small-for-gestational age (SGA) and large-for-gestational age (LGA) are crucial for anticipating and managing potential health complications in newborns. Accurate assessment and planning are key to ensuring optimal infant growth and development.

Area of Science:

  • Neonatalogy
  • Pediatric Growth and Development
  • Maternal-Fetal Medicine

Background:

  • Neonatal size relative to gestational age is a critical factor influencing prenatal and postnatal care.
  • Systematic categorizations (appropriate for gestational age, small-for-gestational age, intrauterine growth restriction, large-for-gestational age) are essential for monitoring fetal and infant growth.
  • Maternal risk factors significantly impact neonatal size and can lead to immediate and long-term health implications.

Purpose of the Study:

  • To provide an overview of neonatal size classifications and their impact on care.
  • To discuss clinical factors associated with small-for-gestational age (SGA) births.
  • To outline the physical assessment, nursing care, and prognostic implications for SGA neonates.

Main Methods:

  • Review of existing literature on neonatal growth classifications and associated complications.
  • Description of systematic categorizations for assessing neonatal size.
  • Explanation of clinical factors contributing to abnormal fetal growth.

Main Results:

  • Abnormal growth descriptors (SGA, LGA) predict potential complications in feeding, glucose utilization, and development.
  • Accurate measurement and plotting on growth charts are vital for confirming visual size assessments.
  • Individualized attention and careful planning are necessary for managing growth complications and ensuring adequate nutrition.

Conclusions:

  • Neonatal size is a critical determinant of health and welfare, requiring careful monitoring and management.
  • Anticipatory guidance based on size-for-gestational age assessment can improve outcomes for neonates at risk of failure to thrive.
  • Understanding size-related complications is essential for providing appropriate prenatal and postnatal care.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...